Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hamilton Thorne Ltd V.HTL

Alternate Symbol(s):  HTLZF

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has single reporting segment being Engaged in Sales to the ART, Research and Cell Biology Markets.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:HTL)

Fundamentals Snapshot (TSXV:HTL)

Opinion & Analysis (TSXV:HTL)

No current opinion is available.

Bullboard Posts (TSXV:HTL)

RE:earnings thoughts

Overall market malaise has kept the shares down.  This company has a very solid position in the rapidly growing IVF market.  ...
dogatcat - 7 days ago

earnings thoughts

I feel good about these especially if you add in the foriegn exchange headwinds (4-5%). In addition ,when the company says  "...
Possibleidiot01 - May 15, 2023

Another blowout earnings announcement!

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2022 Thursday, March 30, 2023, 8:30 AM...
dogatcat - March 30, 2023

Anyone else see the weird trading yesterday?

Volume was way up and thr price action was bizarre.  Looked like someone was buying a 100k in shares in small chunks.  
dogatcat - March 9, 2023

RE:results actually better than headline

Exceptional results and only going to improve.   The demand for their products are growing.  As more and more health plans...
dogatcat - February 23, 2023

results actually better than headline

Hamilton Thorne Announces Record Revenue and Adjusted EBITDA for the Quarter and Year Ended December 31, 2022 These currency...
Possibleidiot01 - February 16, 2023